CLEMASTINE FUMARATE, Doses - CITRATE SALTS, POTASSIUM CITRATE, SODIUM CITRATE & CITRIC ACID

« »

CLEMASTINE FUMARATE

↪ Doses - CLEMASTINE FUMARATE Chemistry - Also known as meclastine fumarate or mecloprodin fumarate, clemastine fumarate isan ethanolamine antihistamine. It occurs as an odorless, faintly yellow, crystalline powder. It is veryslightly soluble in water and sparingly soluble in... ↪ Read more

Doses - CITRATE SALTS, POTASSIUM CITRATE, SODIUM CITRATE & CITRIC ACID

↪ Description - CITRATE SALTS, POTASSIUM CITRATE, SODIUM CITRATE & CITRIC ACID Dogs: For adjunctive therapy to inhibit calcium oxalate crystal formation in dogs with hypocitraturia: Using potassium citrate wax-matrix tablets (Uracit-K®): 150 mg/kg per daydivided into two doses.... ↪ Read more

CITRATE SALTS, POTASSIUM CITRATE, SODIUM CITRATE & CITRIC ACID

↪ Doses - CITRATE SALTS, POTASSIUM CITRATE, SODIUM CITRATE & CITRIC ACID Chemistry - Generally used as alkalinizing agents, citric acid and citrate salts are available inseveral commercially available dosage forms. Citric acid occurs as an odorless or practicallyodorless, colorless,... ↪ Read more

Doses - CISPLATIN

For more information, refer to the protocol references found in the appendix or otherprotocols found in small animal internal medicine references. Additionally, it is strongly recommend to consult the following reference if cisplatin therapy is being considered: Shapiro, W. 1989. Cisplatin... ↪ Read more

CISPLATIN

↪ Doses - CISPLATIN Chemistry - An inorganic platinum-containing antineoplastic, cisplatin occurs as white powder. One mg is soluble in 1 ml of water or normal saline. The drug is available commercially as powderfor injection and as a solution for injection. The powder for injection occurs... ↪ Read more

Doses - CISAPRIDE

Dogs: As a promotility agent: a) 0.5 mg/kg tid; decrease dose if abnormal GI signs or abdominal pain result. (Hall 1994) b) To reduce regurgitation associated with megaesophagus: 0.55 mg/kg PO once to threetimes daily. Practically: 2.5 mg per dose for dogs weighing between 5-10 lbs.; 5 mg perdose... ↪ Read more

CISAPRIDE

↪ Doses - CISAPRIDE Chemistry - An oral GI prokinetic agent, cisapride is a substituted piperidinyl benzamide and isstructurally, but not pharmacologically, related to procainamide. It is available commercially as amonohydrate, but potency is expressed in terms of the anhydrate.Storage,... ↪ Read more

Doses - CIPROFLOXACIN

Dogs: For susceptible infections: a) Ciprofloxacin: 5 - 15 mg/kg PO q12h Avoid or reduce dosage of these drugs in animals with severe renal failure; avoid inyoung animals or in pregnant or breeding animals (Vaden and Papich 1995) b) Ciprofloxacin: 5 - 8 mg/kg PO q12h for UTI; 10 - 15 mg/kg PO q12h... ↪ Read more

CIPROFLOXACIN

↪ Doses - CIPROFLOXACIN Chemistry - A fluroquinolone antibiotic, ciprofloxacin HCl occurs as a faintly yellowish to yellow, crystalline powder. It is slightly soluble in water. Ciprofloxacin is related structurally to theveterinary-approved drug enrofloxacin (enrofloxacin has an additional... ↪ Read more

Doses - CIMETIDINE, CIMETIDINE HCL

↪ Description - CIMETIDINE, CIMETIDINE HCL Dogs: For esophagitis: a) 5 - 10 mg/kg PO q6h (do not give with antacids) (Jones 1985) b) 4 mg/kg PO qid (Watrous 1988) For prevention of drug-induced gastric erosion/ulceration: 5 mg/kg PO, SQ, tid (Schunk1988) For chronic gastritis:5 - 10 mg/kg... ↪ Read more

CIMETIDINE, CIMETIDINE HCL

↪ Doses - CIMETIDINE, CIMETIDINE HCL Chemistry - An H2- receptor antagonist, cimetidine occurs as a white to off-white, crystallinepowder. It has what is described as an "unpleasant" odor and a pKa of 6.8. Cimetidine is sparingly soluble in water and soluble in alcohol. Cimetidine HCl... ↪ Read more

Doses - CHORIONIC GONADOTROPIN (HCG)

↪ Description - CHORIONIC GONADOTROPIN (HCG) Dogs: For cryptorchidism: a) 500 Units injected twice weekly for 4-6 weeks (McDonald 1988) For HCG Challenge test (to determine if testicular tissue remains in castrated male dogs; infemales to diagnose sexual differentiation disorders or if... ↪ Read more